This inventor holds 7 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2020-2025.
Company Filing History:
Years Active: 2020-2025
Title: Kyoko Oguri: Innovator in Diabetes and Obesity Treatment
Introduction
Kyoko Oguri is a prominent inventor based in Shizuoka, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for non-insulin-dependent diabetes mellitus and obesity. With a total of seven patents to her name, her work is recognized for its innovative approach to addressing these health issues.
Latest Patents
Among her latest patents is a pyrazolopyridine derivative that exhibits a GLP-1 receptor agonist effect. This invention provides a compound characterized by a specific structural formula, where the indole ring and the pyrazolopyridine structure are interconnected through a substituent. The patent also covers salts and solvates of the compound, which serve as active ingredients in preventative and therapeutic agents for Type 2 diabetes and obesity.
Career Highlights
Kyoko Oguri is currently employed at Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. Her work at Chugai has allowed her to focus on innovative drug development, contributing to advancements in medical treatments.
Collaborations
Throughout her career, Kyoko has collaborated with notable colleagues, including Satoshi Tsuchiya and Atsushi Matsuo. These collaborations have further enhanced her research and development efforts in the pharmaceutical industry.
Conclusion
Kyoko Oguri's contributions to the field of diabetes and obesity treatment through her innovative patents highlight her role as a leading inventor. Her work continues to impact the pharmaceutical landscape positively.